# “AND” or “OR” logic operations of DNA probes: Fluorescent detection and discrimination of ovarian cancer cells via dual-microRNA in complex environments

**Authors:** Guanghui Wang, Yuting Li, Shuangjie Liu, Jing Li, Meizhen Yao, Jiaxiang Cheng, Ting Chen, Jia Zhang, Fenglei Gao, Wensheng Du, Lei Hua

PMC · DOI: 10.1016/j.mtbio.2025.102454 · 2025-10-23

## TL;DR

This paper introduces a new DNA-based biosensing method using 'AND' or 'OR' logic to detect ovarian cancer cells with high specificity and sensitivity.

## Contribution

The novel contribution is a dual-miRNA detection system using hairpin structures and DNA logic for improved cancer cell discrimination.

## Key findings

- The 'AND' logic pathway requires both miR-221 and miR-96 for fluorescence signal activation with LODs of 0.1792 nM and 0.1990 nM.
- The 'OR' logic pathway allows signal output from either miR-221 or miR-96, with LODs of 0.1020 nM and 0.056 nM, respectively.
- The system shows high specificity in SKOV3 cells and can be adapted to other miRNA combinations through DNA sequence reprogramming.

## Abstract

The development of DNA logic circuits has enabled novel signal carriers for the identification of cancer cells. Addressing the limitations of single-target detection in ovarian cancer, including insufficient specificity and signal delay, this study innovatively constructs a dual-miRNA detection system based on “AND” or “OR” logic operations. In the “AND” logic pathway, both miR-221 (LOD is 0.1792 nM) and miR-96 (LOD is 0.1990 nM) are required to cooperatively trigger strand displacement amplification (SDA) for fluorescence signal activation. In contrast, the “OR” logic pathway enables signal output through either miR-221 or miR-96 (LODs are 0.1020 nM and 0.056 nM, respectively), significantly enhancing sensitivity for low-abundance samples. The core innovation lies in the hairpin structure-mediated miRNA recycling mechanism, where competitive binding allows target molecules to repeatedly participate in reactions, thereby amplifying signal efficiency. This strategy demonstrates high specificity in SKOV3 cells, and its modular design enables rapid adaptation to other miRNA combinations (e.g., miR-21/miR-155) through DNA sequence reprogramming, offering a versatile platform for multi-tumor subtyping. The approach provides new perspectives for intelligent, portable biosensing and bioanalytical applications.

A dual miRNA detection strategy was proposed based on "AND" or "OR" logic operations for ovarian cancer cell identification.Image 1

## Linked entities

- **Diseases:** ovarian cancer (MONDO:0005140)

## Full-text entities

- **Genes:** MIR96 (microRNA 96) [NCBI Gene 407053] {aka DFNA50, MIRN96, hsa-mir-96, miR-96, miRNA96}, MIR221 (microRNA 221) [NCBI Gene 407006] {aka MIRN221, miRNA221, mir-221}, MIR21 (microRNA 21) [NCBI Gene 406991] {aka MIRN21, hsa-mir-21, miR-21, miRNA21}, MIR155 (microRNA 155) [NCBI Gene 406947] {aka MIRN155, miRNA155, mir-155}
- **Diseases:** ovarian cancer (MESH:D010051), cancer (MESH:D009369)
- **Cell lines:** SKOV3 — Homo sapiens (Human), Ovarian serous cystadenocarcinoma, Cancer cell line (CVCL_0532)

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12630042/full.md

---
Source: https://tomesphere.com/paper/PMC12630042